Head and neck cancer: SELENBP1 is downregulated in head and neck squamous cell carcinoma (HNSCC) including nasopharyngeal carcinoma (NPC), laryngeal cancer (LC), oral cancer (OC), tonsil cancer (TC), and hypopharyngeal cancer (HPC), which have no association with tumor T-stage, N-stage, and tumor grade. Here, SELENBP1 is linked to neoplasm.